NPI: 1528232790 · COLUMBUS, OH 43215 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 04/17/2008
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 04/17/2008 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 9,183 | $200K |
| 2019 | 11,704 | $242K |
| 2020 | 14,207 | $425K |
| 2021 | 15,157 | $518K |
| 2022 | 10,802 | $438K |
| 2023 | 6,875 | $463K |
| 2024 | 4,454 | $328K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 28,349 | 2,442 | $2.52M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 14,356 | 1,130 | $70K |
| J1756 | Injection, iron sucrose, 1 mg | 5,421 | 1,258 | $8K |
| A4657 | Syringe, with or without needle, each | 10,928 | 1,422 | $6K |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 1,094 | 110 | $6K |
| J1270 | Injection, doxercalciferol, 1 mcg | 11,032 | 951 | $4K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 556 | 283 | $528.10 |
| 83970 | 70 | 54 | $249.81 | |
| 90674 | 43 | 43 | $152.64 | |
| 82728 | 49 | 41 | $70.64 | |
| G0008 | Administration of influenza virus vaccine | 75 | 74 | $62.60 |
| 82108 | 15 | 12 | $52.75 | |
| 83550 | 47 | 39 | $32.73 | |
| 83540 | 47 | 39 | $25.46 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 26 | 12 | $0.00 |
| 85041 | 146 | 114 | $0.00 | |
| 85048 | 128 | 106 | $0.00 |